BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 15840677)

  • 1. With or without the kidney: the role of FGF23 in CKD.
    Fukagawa M; Kazama JJ
    Nephrol Dial Transplant; 2005 Jul; 20(7):1295-8. PubMed ID: 15840677
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
    Fliser D; Kollerits B; Neyer U; Ankerst DP; Lhotta K; Lingenhel A; Ritz E; Kronenberg F; ; Kuen E; König P; Kraatz G; Mann JF; Müller GA; Köhler H; Riegler P
    J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGF23 and mineral metabolism, implications in CKD-MBD.
    Rodríguez M; López I; Muñoz J; Aguilera-Tejero E; Almaden Y
    Nefrologia; 2012 May; 32(3):275-8. PubMed ID: 22592418
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of fibroblast growth factor-23 in chronic kidney disease.
    Westerberg PA; Linde T; Wikström B; Ljunggren O; Stridsberg M; Larsson TE
    Nephrol Dial Transplant; 2007 Nov; 22(11):3202-7. PubMed ID: 17567652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bone-renal axis in early chronic kidney disease: an emerging paradigm.
    Danziger J
    Nephrol Dial Transplant; 2008 Sep; 23(9):2733-7. PubMed ID: 18469306
    [No Abstract]   [Full Text] [Related]  

  • 6. PTH, FGF-23 and early CKD.
    Rodriguez M; Felsenfeld AJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3391-3. PubMed ID: 18676347
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of fibroblast growth factor 23 in renal disease.
    Jonsson KB
    Nephrol Dial Transplant; 2005 Mar; 20(3):479-82. PubMed ID: 15735238
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.
    Stubbs J; Liu S; Quarles LD
    Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Klotho in chronic kidney disease--what's new?
    Kuro-o M
    Nephrol Dial Transplant; 2009 Jun; 24(6):1705-8. PubMed ID: 19225012
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal and extrarenal effects of fibroblast growth factor 23.
    Vervloet M
    Nat Rev Nephrol; 2019 Feb; 15(2):109-120. PubMed ID: 30514976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of FGF-23 in CKD-MBD and cardiovascular disease: friend or foe?
    Larsson TE
    Nephrol Dial Transplant; 2010 May; 25(5):1376-81. PubMed ID: 20124546
    [No Abstract]   [Full Text] [Related]  

  • 12. FGF-23: state of the art.
    Oliveira RB; Moysés RM
    J Bras Nefrol; 2010; 32(3):323-31. PubMed ID: 21103697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of calcium and phosphate metabolism impairment in chronic kidney disease.
    Cozzolino M; Ciceri P; Volpi EM; Olivi L; Messa PG
    Blood Purif; 2009; 27(4):338-44. PubMed ID: 19295196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between circulating FGF23 and total body atherosclerosis in the community.
    Mirza MA; Hansen T; Johansson L; Ahlström H; Larsson A; Lind L; Larsson TE
    Nephrol Dial Transplant; 2009 Oct; 24(10):3125-31. PubMed ID: 19429932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 23 and its receptors.
    Yu X; White KE
    Ther Apher Dial; 2005 Aug; 9(4):308-12. PubMed ID: 16076372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF23 and PTH--double agents at the heart of CKD.
    Silver J; Rodriguez M; Slatopolsky E
    Nephrol Dial Transplant; 2012 May; 27(5):1715-20. PubMed ID: 22447519
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of bone in phosphate metabolism.
    Fukumoto S
    Mol Cell Endocrinol; 2009 Oct; 310(1-2):63-70. PubMed ID: 18822343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
    Nagano N; Miyata S; Abe M; Wakita S; Kobayashi N; Wada M
    Clin Calcium; 2005 Sep; 15 Suppl 1():35-9; discussion 39-40. PubMed ID: 16272627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reporting the eGFR and its implication for CKD diagnosis.
    Botev R; Mallié JP
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1606-7. PubMed ID: 18922981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Second chances in mineral metabolism.
    Wolf M
    Clin J Am Soc Nephrol; 2010 Jan; 5(1):1-3. PubMed ID: 20007676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.